Azienda Ospedaliera S. Camillo-Forlanin

Rome 00152

0 studies enrolling now · 2 studies all time

What they study most

Lung Cancer, Non-Small Cell Lung Cancer

Studies at this site

• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer — Completed